1Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology, 1997, 48(6): 1613-1619.
2Najim al Din AS, Mubaidin A, Wriekat AL, et al. Risk factors of aseptic intracranial venous occlusive disease. Acta Neurol Scand, 1994,90(6): 412-416.
3Wechsler B, Vidailhet M, Piette JC, et al. Cerebral venous thrombosis in Behcet' s disease: clinical study and long-term follow-up of 25 cases.Neurology, 1992, 42(3 pt 1): 614-618.
4Crawford SC, Digre KB, Palmer CA, et al. Thrombosis for the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol, 1995,52 ( 11 ): 1101-1108.
6Brucker AB, Vollert Rogenhofer H, Wagner M, et al. Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis, 1998, 8(6): 331-337.
7Einhaupl KM, Villringer A, Meister W, et al. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke, 1999, 30(3):481483.
8Einhanpl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet, 1991, 338(8767): 597-600.
9The Columbus Investigators. Low-moleeular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med, 1997,337(10): 657-662.
10de Bruijn SF, Snam J. Randomized, placebo controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke, 1999, 30(3): 484-488.
